Filtros de búsqueda

Lista de obras de Luca Castagna

A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor

artículo científico publicado en 2014

Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation

artículo científico publicado en 2012

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

artículo científico publicado en 2021

Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.

artículo científico publicado en 2013

Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party

artículo científico publicado en 2014

Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry

artículo científico publicado en 2013

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.

artículo científico publicado en 2015

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.

artículo científico publicado en 2012

Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease

artículo científico publicado en 2001

Allogeneic peripheral stem-cell transplantation with reduced-intensity conditioning regimen in refractory primary B-cell prolymphocytic leukemia: a long-term follow-up

scientific article published on 01 June 2005

Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma

artículo científico publicado en 2009

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment

artículo científico publicado en 2013

Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome

scientific article published on 15 November 2020

Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?

artículo científico publicado en 2012

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability

artículo científico publicado en 2010

Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease

artículo científico publicado en 2013

Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?

artículo científico publicado en 2012

B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY

artículo científico publicado en 2014

Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

artículo científico publicado en 2016

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide

artículo científico publicado en 2014

Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamide.

artículo científico publicado en 2016

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers

artículo científico publicado en 2015

Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party.

artículo científico publicado en 2018

CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide.

artículo científico publicado en 2018

CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.

artículo científico publicado en 2007

Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma

artículo científico publicado en 2012

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.

artículo científico publicado en 2016

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.

artículo científico publicado en 2018

Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

artículo científico publicado en 2015

Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years.

artículo científico publicado en 2018

Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.

artículo científico

Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma.

artículo científico publicado en 2015

Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantation.

artículo científico publicado en 2016

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

artículo científico publicado en 2012

Donor CD3(+) lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: single-center experience

artículo científico publicado en 2012

Donor lymphocyte infusion after allogeneic stem cell transplantation

artículo científico publicado en 2016

Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation.

artículo científico publicado en 2016

ECIL 3-2009 update guidelines for antifungal management

artículo científico publicado en 2011

Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: a case report

artículo científico publicado en 2013

Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors.

artículo científico publicado en 1993

Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?

article by Paolo Perseghin et al published 1 April 2007 in Therapeutic Apheresis and Dialysis

Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available

scientific article published on 01 June 2015

Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available

artículo científico publicado en 2015

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution

scientific article published on 01 August 2003

First-line extracorporeal photochemotherapy for acute GVHD after unmanipulated haploidentical BMT following nonmyeloablative conditioning and post transplantation CY.

artículo científico publicado en 2013

Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia

artículo científico publicado en 2003

Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Relate

artículo científico publicado en 2015

Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients

artículo científico publicado en 2020

High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens

artículo científico publicado en 2005

High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin

artículo científico publicado en 2005

High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients

artículo científico publicado en 2005

High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study

artículo científico publicado en 2002

High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: a matched analysis

scientific article published on 01 August 2003

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant

artículo científico publicado en 2015

Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor

artículo científico publicado en 2016

IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients

artículo científico publicado en 2007

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

artículo científico publicado en 2013

Idiopathic thrombocytopenic purpura and splenic marginal-zone B-cell lymphoma: a casual correlation?

artículo científico publicado en 2003

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma

artículo científico publicado en 2007

Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantation

artículo científico publicado en 2013

Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant

artículo científico publicado en 2010

Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.

artículo científico publicado en 2015

Inhibition of chronic graft-vs-host disease with retention of anti-myeloma effects by the proteasome inhibitor bortezomib

artículo científico publicado en 2007

Intensified CHOP in non-Hodgkin's lymphoma: what we know and what we need to know

scientific article published on 01 August 1999

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide

artículo científico publicado en 2002

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

artículo científico publicado en 2004

Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy.

artículo científico publicado en 2013

Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?

artículo científico publicado en 2006

Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

artículo científico publicado en 2016

JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature.

artículo científico publicado en 2012

Lack of activity of allogeneic stem cell transplantation with reduced-intensity conditioning regimens in advanced sarcomas

scientific article published on 01 February 2005

Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma

artículo científico publicado en 2012

Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.

artículo científico publicado en 2012

Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications

artículo científico publicado en 2006

Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients

artículo científico publicado en 2016

Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial

artículo científico publicado en 2014

Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?

artículo científico publicado en 2004

Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen

artículo científico publicado en 2003

Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

artículo científico publicado en 2003

Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma

artículo científico publicado en 2001

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen

artículo científico publicado en 2014

Nonmyeloablative allogenic peripheral-blood stem-cell transplantation in pancreatic adenocarcinoma: one case, high expectations

artículo científico publicado en 2004

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

artículo científico publicado en 2014

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients

artículo científico publicado en 2012

Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.

artículo científico publicado en 2016

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.

artículo científico publicado en 2017

Parvovirus B19 as an etiological agent of acute pleuro-pericarditis

scientific article published on 26 April 2010

Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT

artículo científico publicado en 2015

Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma

artículo científico publicado en 2012

Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation

artículo científico publicado en 2014

Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.

artículo científico publicado en 2012

Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation

scientific article published on 05 May 2016

Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients

scientific article published on 06 November 2018

Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation

scientific article published on 18 September 2019

Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.

artículo científico publicado en 2009

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell t

artículo científico publicado en 2010

Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate

artículo científico publicado en 2001

Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy

artículo científico publicado en 2005

Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.

artículo científico

Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients.

artículo científico publicado en 2011

Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients

artículo científico publicado en 2006

Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour.

artículo científico publicado en 2003

QUANTITATIVE ANALYSIS OF T HELPER 1, T HELPER 2, AND INFLAMMATORY CYTOKINE EXPRESSION IN PATIENTS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION

article

Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation

artículo científico publicado en 2012

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long term disease control. An analysis from the Lymphoma Working Party Of the EBMT.

artículo científico publicado en 2016

Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas

artículo científico publicado en 2002

Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation

artículo científico publicado en 2007

Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion

artículo científico publicado en 2007

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

artículo científico publicado en 2014

Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies

artículo científico publicado en 2010

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

artículo científico publicado en 2014

Response to immunosuppressive treatment predicts outcome in patients with chronic graft-versus-host disease: a single-center analysis of longitudinal data.

artículo científico publicado en 2012

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

artículo científico publicado en 2010

Rituximab in thrombotic microangiopathy

scientific article published on 01 October 2007

Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

artículo científico publicado en 2015

Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and Outcomes

artículo científico publicado en 2020

Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen

artículo científico publicado en 2004

Successful donor lymphocyte infusion (DLI) in a patient with myelodysplastic syndrome (MDS) after failure of T-cell-depleted bone marrow transplantation (TD-BMT)

artículo científico publicado en 1998

Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapy.

artículo científico publicado en 2012

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.

artículo científico publicado en 2015

TLI in refractory chronic GVHD

artículo científico publicado en 2012

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

scientific article published on 23 November 2015

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma

artículo científico publicado en 2012

Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients.

artículo científico publicado en 2015

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.

artículo científico publicado en 2017

Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.

artículo científico publicado en 2007

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo

artículo científico publicado en 2013

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

artículo científico publicado en 2016

The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-ris

artículo científico publicado en 2016

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

artículo científico publicado en 2012

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide

artículo científico publicado en 2019

The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest.

artículo científico publicado en 2016

The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide.

artículo científico publicado en 2016

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

artículo científico publicado en 2011

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases

artículo científico publicado en 2012

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma

scientific article published on 04 November 2013

Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies

artículo científico publicado en 2015

Vertebroplasty for pain relief and spinal stabilization in multiple myeloma

artículo científico publicado en 2010

Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study.

artículo científico publicado en 2014

[Advances in haploidentical transplantation in hematological malignancies].

artículo científico publicado en 2012

[Allogeneic hematopoietic stem cell transplantation in elderly]

scientific article published on 01 August 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda